Brain metastases occur in up to 40% of patients with cancer.
Comparisons
We compared two radiosurgery modalities: (a) Robotic radiosurgery; and (b) Fixed-gantry radiosurgery. We compared resource volumes including planning and treatment times in patients who received Robotic radiosurgery to patients who received Fixed-gantry radiosurgery.
Radiosurgery
Radiosurgery refers to stereotactically guided conformal irradiation of a defined target volume in a single session; when delivered in two to five sessions, the procedure is called fractionated radiosurgery. Stereotaxis refers to a precise threedimensional (3D) mapping technique to guide a procedure.
Robotic radiosurgery
At JCC, Cyberknife® is used for robotic radiosurgery. Radiation therapists position the patient supine and immobilize the head with a thermoplastic face mask. Next, they perform a CT simulation with slice thickness in the range of 1.0 -1.25 mm. After the images are exported to the planning software, a dosimetrist performs a fusion between simulation computed tomogram (CT) and a gadolinium enhanced T1 weighted magnetic resonance imaging (MRi) (slice thickness of 1 mm) obtained within two weeks of expected treatment date. The dosimetrist also sets up a reference point called 'alignment centre' on the simulation CT ( Figure 1A ). The radiation oncologist and the neurosurgeon delineate the clinical target volumes (CTvs). Clinical target volumes comprises of the gross lesion including its enhancing component. The dosimetrist geometrically expands each CTv by 1 mm to planning target volume (pTv). if the CTv abutts a critical organ (e.g., brain stem), no pTv expansion is given at the interface between CTv and the critical organ. The radiation oncologist prescribes the dose to the pTv which depends on the maximal dimension. The dosimetrist generates a plan in which 50-200 beams from various directions and path lengths traverse the pTv. The dose is prescribed to the isodose line that covers 95% of the pTv, which is typically 65-85% isodose line (when the plan is normalized to maximum point dose). This results in > 100% of the prescription dose in the centre of the pTv, and in a steep dose gradient outside the pTv wherein the dose rapidly falls off. The physicist reviews the plan and the radiation oncologist approves it. The planning system generates two sets of digitally reconstructed radiographs (DRRs) for alignment and lesion tracking.
At the time of treatment delivery, therapists position and immobilize the patient as before. The alignment centre on the reference DRRs is aligned to the imaging centre ( Figure 1B ). The imaging centre provides the 3D coordinates for stereotaxis. it is a point in space in the treatment unit which is intersected by two orthogonal kilovoltage beams from two cameras located on the ceiling. Two image detectors located on the opposite side of the floor detect these beams. These cameras continuously take images in real time which are matched to the reference DRRs for target localization. The robot on which the linear accelerator is mounted corrects for any misalignment at the time of set up and during the course of treatment delivery.
Fixed-gantry based radiosurgery
At JCC, varian Trilogy® linac with brain lab radiosurgery hardware and software is used. The therapists position the patient supine and immobilize patient's head in a re-locatable stereotactic frame that provides the 3D co-ordinates for stereotaxis ( Figure 1C ). The rest of the planning is similar except that arcs and multiple isocenters are used for each target.
At the time of treatment delivery, the therapists set up the patient as before. They use a cone beam CT scanner which is attached to the linear accelerator to acquire set-up images. They match the images by fusion to the planning CT overlaying them ( Figure 1D ). The radiation oncologist reviews the images for an acceptable match. if unacceptable, the therapists manually shift and or rotate the head frame to correct the misalignment. They re-acquire the cone beam CT images for matching until an acceptable match is obtained. The linear accelerator delivers radiation to the lesion. Unlike the CyberKnife, the residual errors are not corrected, but are kept below 1 mm and 1 degree. The therapists repeat the whole process for the next lesion or isocenter. Fixed gantry treatments are planned and delivered using fixed cones or dynamic conformal multi-leaf collimators in four to six arcs.
Type of evaluation and perspective
We carried out economic evaluation of treating one to three brain metastases patients with Robotic radiosurgery from a payer's perspective. This involved calculating incremental cost per patient and the total budget impact.
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The model
The starting point of the model was a cohort of patients assigned to Robotic radiosurgery or to Fixed-gantry radiosurgery. The patients underwent initial clinical assessment, followed up treatment planning and delivery. Thereupon, they were seen in review clinic and once again in follow-up. They were then discharged to be followed by the referring physician. The time span of the model was one year.
Assumptions
We assumed that: (1) both radiosurgery modalities were equally effective and equally safe; (2) all patients consented for the treatment, and remained stable during the planning, treatment and follow-up; (3) fixed-gantry system operated for ten hours daily, five days a week and it treated other diseases besides brain metastases, but robotic system operated for six hours daily, five days a week and it treated a limited number of other diseases; and (4) each system was acquired through a bank loan for ten years.
Data sources
For population characteristics, and resource volumes, we used local estimates. For unit prices, we used local purchase data, and Ontario Health insurance (OHip) billing codes, 10 where applicable; for long term investment items (e.g., machines), we used 5% interest rate and ten year amortization period to calculate annual payments. Table 1 shows resource volumes.
Resource volumes
Using means, standard deviations, and minimum-maximum values for continuous data, and proportions for dichotomous data, we used Monte Carlo simulation to generate resource volumes of planning and treatment times stratified by solitary versus multiple brain metastases. A newly launched study provided planning and treatment times.
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Costs
To capture all costs, i.e., those of the equipment plus those related to its administration and maintenance, and other costs related to clinical assessment, treatment planning, delivery and follow up, we included cost items as machine, renovation, warranty, immobilization device, physician fees, salaries of nurses, therapists, and physicists (Table 2) . We did not include costs related to loss of productivity from hospitalization, disability or death; we excluded patients' out-of-pocket expenses. Finally, we multiplied the unit prices of cost items with resource volumes to compute the total costs for the two groups.
Outcomes
The main outcome was cost per patient related to each modality. We did not include overall survival, quality adjust life years, or toxicity because there are no data to suggest that one modality is better than the other for any of these outcomes. 3 
Analysis
First, we calculated cost per patient for both groups. Next, we subtracted cost per patient of robotic group from that of fixedgantry group. This yielded the incremental cost/patient attributable to robotic radiosurgery. Since time span was one year, we did not apply any discounting to costs.
To account for the uncertainty in daily hours of operation, we performed a sensitivity analysis by varying this parameter from two hours (low volume setting) to ten hours (high volume setting). To account for uncertainty in percentage of patients with multiple lesions out of the total patients, we varied this parameter from 0% to 100%. in addition, we performed a probabilistic analysis by using Monte Carlo simulations on treatment times and number of lesions, and computed 95% intervals on the incremental cost/patient.
For budget impact, we took the difference of annual cost of acquiring the unit (purchase and installment) and its maintenance, between robotic and fixed-gantry systems. We assumed a variation of ± 5% in purchase price, and up to 15% increment in repair costs depending upon utilization.
We reported costs in Canadian dollars (one Canadian dollar (CAD) = 1.01 United States of America (US) dollar; Dec 2012).
RESULTS
Both groups had similar patient characteristics. in each group, 45% had solitary metastasis, 39% had two and 16% had three metastases. Treatment planning time was approximately six hours in each group. However, treatment delivery time was 60 ± 5 minutes in the robotic group, and 140 ± 45 minutes in the fixed-gantry group.
The cost of radiosurgery was $4,783/patient for robotic and $5,166/patient for fixed-gantry system. in sensitivity analyses, the cost of robotic radiosurgery varied from $5,656/patient in low volume setting to $4,492/patient in high volume setting.
When the percentage of patients with multiple lesions out of the total patients, was varied from 0% to 100%, the cost of fixedgantry radiosurgery was higher than the cost of robotic radiosurgery except when <10% patients had multiple lesions (Figure 2) .
The incremental cost/patient was $-383 (95% interval: $-670, $110) for all lesions, $78 ($23, $123) for solitary lesions, and $-610 ($-679, $-534) for multiple lesions. The annual budget impact was $151,776 ($144,478, $159,947).
DISCUSSION
We compared the cost effectiveness of robotic radiosurgery to fixed gantry radiosurgery for the treatment of one to three brain metastases. When total investment costs were considered, robotic radiosurgery was more costly than fixed-gantry-based radiosurgery. When cost per patient was considered, robotic radiosurgery was more cost effective than fixed-gantry-based radiosurgery. When number of lesions were considered (single versus multiple), cost per patient was lower for fixed-gantry radiosurgery for solitary lesions, compared to robotic radiosurgery. This was related to longer treatment times associated with multiple lesions for fixed-gantry radiosurgery.
There is limited literature on the cost effectiveness of radiation therapy for brain metastases. Of the studies in US, lal and colleagues estimated that the cost of radiosurgery plus whole brain radiation was $74,000, and the cost of radiosurgery alone was $119,000 (US$). 12 in their study, radiosurgery was delivered by a fixed-gantry system to patients with Recursive partition Analysis (RpA) class 1 or 2 and one to three brain metastases. From the perspective of a tertiary care cancer centre, they collected costs of the initial treatment as well as subsequent treatments (i.e., for local recurrence with radiation/surgery) up to death or end of study period (median follow-up 9.5 months). We limited our cost analysis from the time of referral to a radiation oncologist to one year post treatment. Thus, our estimate of radiosurgery cost ($5,166) is relatively low. However, our results are similar to Mehta and colleagues. 13 They used their local hospital's cost-accounting system to generate costs -the cost of whole brain radiation was $6,500 and the cost of whole brain radiation plus radiosurgery was $15,102 (US$).
in a european study, vuong and colleagues estimated the cost of initial radiosurgery with Gamma knife and subsequent local treatments to be €9,964 ($12,998 CAD).
14 Their costing was based on a payer's perspective from time of initial treatment to death or 5.5 years of follow-up. They excluded costs of followup visits, and adjunct treatments (chemotherapy, palliative, rehabilitation). When the differences in costing methods and study setting, are taken into account, their results appear similar to ours. Nevertheless, we have described the cost items and resource volumes so that by using local unit prices, decision makers could generate cost estimates in their own settings.
Our results are sensitive to patient volume. This finding is in agreement with the cost analysis of Kӧnigsmaier and colleagues. 15 They compared cost of radiosurgery with Gamma knife in comparison with a fixed-gantry system. The cost of Gamma knife was DM 13,106 in low volume setting and DM 4,002 in high volume setting; the corresponding cost of fixedgantry radiosurgery was DM 13,616 and DM 4,328. Thus, cancer centres that do not have enough patients to use the robotic system for six to eight hours daily may choose to commission their fixed gantry units for stereotactic application, rather than investing in a dedicated robotic system.
Our results should be used in the context of study limitations. First, we performed costing from the payer's perspective. Thus, out-of-pocket patient costs associated with commuting and parking were not captured. Since, robotic radiosurgery is associated with shorter treatment time, the inclusion of these costs would further favor robotic over fixed-gantry radiosurgery. Second, the longer treatment time associated with fixed-gantry radiosurgery was due to manual shifts and rotation of the couch to achieve an image match. A robotic couch is commercially available for fixed-gantry radiosurgery that may allow faster treatment delivery times compared to a manual couch. However, when the price of a robotic couch is added to the price of fixedgantry system, the total price equals that of a robotic radiosurgery system. Finally, we did not perform cost utility analyses. There are no data to suggest a difference in survival or quality of life with the use of robotic radiosurgery compared to fixed-gantry radiosurgery. On the contrary, a subgroup analysis of RTOG 9508 showed that dedicated radiosurgery (Gamma knife®) and fixed gantry based radiosurgery were equivalent when survival was compared. 3 Thus, we do not believe that omission of these analyses would alter our conclusions. Nevertheless, this is under investigation.
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CONCLUSIONS
in settings of moderate to high volume (six to ten hours of daily operation), and in multiple lesions, robotic radiosurgery is more cost effective than fixed-gantry radiosurgery. However, robotic radiosurgery has higher budget impact than fixed-gantry radiosurgery. Thus, decision-makers need to judge whether there is enough patient volume in their own setting to offset the budget impact of robotic radiosurgery.
